MedPath

OM1, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions

Conditions
Alopecia Areata
Dermatology
Hidradenitis Suppurativa
Vitiligo
Atopic Dermatitis
Psoriasis
First Posted Date
2021-10-19
Last Posted Date
2023-11-01
Lead Sponsor
OM1, Inc.
Target Recruit Count
10000
Registration Number
NCT05084417
Locations
๐Ÿ‡บ๐Ÿ‡ธ

OM1, Boston, Massachusetts, United States

Implementation of Harmonized Depression Outcome Measures in a Health System

Completed
Conditions
Dysthymia
Major Depression
First Posted Date
2020-01-22
Last Posted Date
2021-05-18
Lead Sponsor
OM1, Inc.
Target Recruit Count
5
Registration Number
NCT04235712
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baystate Health, Springfield, Massachusetts, United States

Implementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health Registry

Completed
Conditions
Major Depression
Dysthymia
First Posted Date
2020-01-22
Last Posted Date
2021-05-18
Lead Sponsor
OM1, Inc.
Target Recruit Count
953
Registration Number
NCT04235725
Locations
๐Ÿ‡บ๐Ÿ‡ธ

American Psychiatric Association, Washington, District of Columbia, United States

๐Ÿ‡บ๐Ÿ‡ธ

American Board of Family Medicine, Lexington, Kentucky, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.